MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fosse, P.
Right arrow Articles by Saucier, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fosse, P.
Right arrow Articles by Saucier, J. M.

Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationship

P Fosse, B Rene, M Charra, C Paoletti and JM Saucier

Laboratoire de Biochimie-Enzymologie, CNRS URA147, INSERM U140, Institut Gustave Roussy, Villejuif, France.

Ellipticines are aromatic compounds that intercalate between DNA base pairs and display significant antitumor activity. The cytotoxicity of these compounds is mediated by DNA topoisomerase II, and the presence of a hydroxy group at position 9 of the pyridocarbazole ring system of ellipticines has been found to be essential for high levels of cytotoxicity. The ability of 13 ellipticine derivatives to stabilize the topoisomerase II-DNA covalent complex in vitro was studied, and the data obtained with five pairs of hydroxylated and nonhydroxylated analogues indicate that the hydroxy group at position 9 plays a crucial role in the stabilization of the complex. The influence, upon the complex stabilization, of various substituents at positions 1, 2, 5, and 6 of the pyridocarbazole ring system was investigated. The interaction with DNA of four ellipticine derivatives was studied in the topoisomerase II standard medium. Results suggest that the degree of unwinding might be a determinant of topoisomerase II-DNA-drug complex stability. In addition, the 5-ethyl derivative was observed to induce covalent complex stabilization by a cooperative mechanism.

Volume 42, Issue 4, pp. 590-595, 10/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
D. Aimova, L. Svobodova, V. Kotrbova, B. Mrazova, P. Hodek, J. Hudecek, R. Vaclavikova, E. Frei, and M. Stiborova
The Anticancer Drug Ellipticine Is a Potent Inducer of Rat Cytochromes P450 1A1 and 1A2, Thereby Modulating Its Own Metabolism
Drug Metab. Dispos., October 1, 2007; 35(10): 1926 - 1934.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Malonne, S. Farinelle, C. Decaestecker, L. Gordower, J. Fontaine, F. Chaminade, J.-M. Saucier, G. Atassi, and R. Kiss
In Vitro and in Vivo Pharmacological Characterizations of the Antitumor Properties of Two New Olivacine Derivatives, S16020-2 and S30972-1
Clin. Cancer Res., September 1, 2000; 6(9): 3774 - 3782.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
S. Le Mée, A. Pierré, J. Markovits, G. Atassi, A. Jacquemin-Sablon, and J.-M. Saucier
S16020-2, a New Highly Cytotoxic Antitumor Olivacine Derivative: DNA Interaction and DNA Topoisomerase II Inhibition
Mol. Pharmacol., February 1, 1998; 53(2): 213 - 220.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics